Clinical Trial Update: A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether losartan provides renal protective effects in patients with type 2 diabetes and nephropathy; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Losartan (losartan)

Snippet

Sponsor: Organon and Co | Conditions: Type 2 Diabetes, Nephropathy | Phase 3 | Status: COMPLETED